Solluce的个人主页 - 老虎社区

Solluce

Solluce

暂无个人介绍

IP属地：未知

14关注

3粉丝

0主题

0勋章

2021-12-16

Kay

Kaixin Auto rose 25% in morning trading as it won an order agreement for 10,000 new energy trucks

2021-12-15

Like pls, ty!

Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival

2021-12-14

Like pls!

U.S.Stocks open lower after PPI reading as investors await Fed

2021-12-14

Like pls. Ty!

2 Warren Buffett Dividend Stocks to Buy Right Now

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4102250035568310,"uuid":"4102250035568310","gmtCreate":1639147436551,"gmtModify":1639495970942,"name":"Solluce","pinyin":"solluce","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/646eb0ac8d22985e48ba886e5c0e7fc4","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":14,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.04.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":690645245,"gmtCreate":1639666403489,"gmtModify":1639666403558,"author":{"id":"4102250035568310","authorId":"4102250035568310","name":"Solluce","avatar":"https://static.tigerbbs.com/646eb0ac8d22985e48ba886e5c0e7fc4","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Kay","listText":"Kay","text":"Kay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690645245","repostId":"1171328517","repostType":4,"repost":{"id":"1171328517","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639666148,"share":"https://www.laohu8.com/m/news/1171328517?lang=&edition=full","pubTime":"2021-12-16 22:49","market":"us","language":"en","title":"Kaixin Auto rose 25% in morning trading as it won an order agreement for 10,000 new energy trucks","url":"https://stock-news.laohu8.com/highlight/detail?id=1171328517","media":"Tiger Newspress","summary":"Kaixin Auto rose 25% in morning trading as it won an order agreement for 10,000 new energy trucks.Be","content":"<p>Kaixin Auto rose 25% in morning trading as it won an order agreement for 10,000 new energy trucks.<img src=\"https://static.tigerbbs.com/d374503429ec3624076f5d7dbddb0bec\" tg-width=\"771\" tg-height=\"557\" width=\"100%\" height=\"auto\">Beijing Bujia International Logistics Limited has agreed to order at least 10,000 new energy trucks over the next five years, with a deal worth more than $500 million, it said.</p>\n<p>Lin Mingjun, chairman and CEO of Kaixin Auto Group, said that the company's R&amp;D team is working on product design to meet Bujia's needs, which is expected to be released in the first quarter of next year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kaixin Auto rose 25% in morning trading as it won an order agreement for 10,000 new energy trucks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKaixin Auto rose 25% in morning trading as it won an order agreement for 10,000 new energy trucks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-16 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Kaixin Auto rose 25% in morning trading as it won an order agreement for 10,000 new energy trucks.<img src=\"https://static.tigerbbs.com/d374503429ec3624076f5d7dbddb0bec\" tg-width=\"771\" tg-height=\"557\" width=\"100%\" height=\"auto\">Beijing Bujia International Logistics Limited has agreed to order at least 10,000 new energy trucks over the next five years, with a deal worth more than $500 million, it said.</p>\n<p>Lin Mingjun, chairman and CEO of Kaixin Auto Group, said that the company's R&amp;D team is working on product design to meet Bujia's needs, which is expected to be released in the first quarter of next year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KXIN":"开心汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171328517","content_text":"Kaixin Auto rose 25% in morning trading as it won an order agreement for 10,000 new energy trucks.Beijing Bujia International Logistics Limited has agreed to order at least 10,000 new energy trucks over the next five years, with a deal worth more than $500 million, it said.\nLin Mingjun, chairman and CEO of Kaixin Auto Group, said that the company's R&D team is working on product design to meet Bujia's needs, which is expected to be released in the first quarter of next year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607550748,"gmtCreate":1639568109027,"gmtModify":1639568109255,"author":{"id":"4102250035568310","authorId":"4102250035568310","name":"Solluce","avatar":"https://static.tigerbbs.com/646eb0ac8d22985e48ba886e5c0e7fc4","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like pls, ty!","listText":"Like pls, ty!","text":"Like pls, ty!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607550748","repostId":"1160618167","repostType":4,"repost":{"id":"1160618167","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639551825,"share":"https://www.laohu8.com/m/news/1160618167?lang=&edition=full","pubTime":"2021-12-15 15:03","market":"us","language":"en","title":"Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival","url":"https://stock-news.laohu8.com/highlight/detail?id=1160618167","media":"Benzinga","summary":"Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in t","content":"<p>Popular investment&nbsp;management firm&nbsp;<b>Ark Invest,</b>led by&nbsp;<b>Cathie Wood,</b>on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV) on the dip.</p>\n<p>Ark Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.</p>\n<p>Xpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.</p>\n<p>Xpeng and other Chinese peer shares such as&nbsp;<b>Nio Inc</b>(NYSE:NIO) have been under pressure recently.</p>\n<p>Xpeng bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.</p>\n<p>Each of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p>\n<p>Xpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.</p>\n<p>The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p>\n<p>Ark Invest bought shares in Xpeng via the&nbsp;<b>ArkAutonomous Technology &amp; Robotics ETF</b>.</p>\n<p>ARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.</p>\n<p><b>Tesla Inc</b>&nbsp;is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p>\n<p>The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p>\n<p>Tesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.</p>\n<p>Here are a few other key Ark trades from Tuesday:</p>\n<ul>\n <li>Bought 11,671 shares — estimated to be worth $3 million — in&nbsp;<b>Coinbase</b>&nbsp;<b>Global Inc</b>. The stock closed 1.79% higher at $255.86 a share on Tuesday.</li>\n <li>Sold 56,925 shares — estimated to be worth $4.4 million — in<b>JD.com Inc</b>. The stock closed 0.51% lower at $77.65 a share.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-15 15:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Popular investment&nbsp;management firm&nbsp;<b>Ark Invest,</b>led by&nbsp;<b>Cathie Wood,</b>on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV) on the dip.</p>\n<p>Ark Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.</p>\n<p>Xpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.</p>\n<p>Xpeng and other Chinese peer shares such as&nbsp;<b>Nio Inc</b>(NYSE:NIO) have been under pressure recently.</p>\n<p>Xpeng bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.</p>\n<p>Each of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p>\n<p>Xpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.</p>\n<p>The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p>\n<p>Ark Invest bought shares in Xpeng via the&nbsp;<b>ArkAutonomous Technology &amp; Robotics ETF</b>.</p>\n<p>ARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.</p>\n<p><b>Tesla Inc</b>&nbsp;is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p>\n<p>The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p>\n<p>Tesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.</p>\n<p>Here are a few other key Ark trades from Tuesday:</p>\n<ul>\n <li>Bought 11,671 shares — estimated to be worth $3 million — in&nbsp;<b>Coinbase</b>&nbsp;<b>Global Inc</b>. The stock closed 1.79% higher at $255.86 a share on Tuesday.</li>\n <li>Sold 56,925 shares — estimated to be worth $4.4 million — in<b>JD.com Inc</b>. The stock closed 0.51% lower at $77.65 a share.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车","ARKQ":"ARK Autonomous Technology & Robotics ETF","JD":"京东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160618167","content_text":"Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker Xpeng Inc(NYSE:XPEV) on the dip.\nArk Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.\nXpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.\nXpeng and other Chinese peer shares such as Nio Inc(NYSE:NIO) have been under pressure recently.\nXpeng bolted ahead of local rivals Nio and Li Auto Inc(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.\nEach of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.\nXpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.\nThe maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.\nArk Invest bought shares in Xpeng via the ArkAutonomous Technology & Robotics ETF.\nARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.\nTesla Inc is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.\nThe investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.\nTesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.\nHere are a few other key Ark trades from Tuesday:\n\nBought 11,671 shares — estimated to be worth $3 million — in Coinbase Global Inc. The stock closed 1.79% higher at $255.86 a share on Tuesday.\nSold 56,925 shares — estimated to be worth $4.4 million — inJD.com Inc. The stock closed 0.51% lower at $77.65 a share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607191106,"gmtCreate":1639494999427,"gmtModify":1639494999491,"author":{"id":"4102250035568310","authorId":"4102250035568310","name":"Solluce","avatar":"https://static.tigerbbs.com/646eb0ac8d22985e48ba886e5c0e7fc4","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like pls!","listText":"Like pls!","text":"Like pls!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607191106","repostId":"1179453620","repostType":4,"repost":{"id":"1179453620","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639492308,"share":"https://www.laohu8.com/m/news/1179453620?lang=&edition=full","pubTime":"2021-12-14 22:31","market":"us","language":"en","title":"U.S.Stocks open lower after PPI reading as investors await Fed","url":"https://stock-news.laohu8.com/highlight/detail?id=1179453620","media":"Tiger Newspress","summary":"U.S.Stocks open lower after PPI reading as investors await Fed,Nasdaq Composite down 1.2% at 15,229.","content":"<p>U.S.Stocks open lower after PPI reading as investors await Fed,Nasdaq Composite down 1.2% at 15,229.96,S&amp;P 500 down 0.7% at 4,635.65,Dow industrials down 98 points, or 0.3%.</p>\n<p>Tesla&nbsp;shares were among the biggest early droppers on the S&amp;P 500, falling 2.1% premarket after CEO Elon Musk announced that that he has sold another $906.5 million in shares.</p>\n<p>Fellow automaker&nbsp;Ford&nbsp;also fell, down 1.7% following news that by 2030Toyotawould beinvesting $35 billion into battery-powered electronic vehicles, a space where Ford has sought to establish itself as a leader.</p>\n<p>Pfizer&nbsp;shares rose nearly 1% after final results of tests on its Covid drug showed it reduced hospitalizations and deaths by 89% in high-risk patients.</p>\n<p>Research from Goldman Sachs showed&nbsp;the S&amp;P 500 is powered by five stocks&nbsp;that have accounted for 51% of its return since the end of April. Microsoft, Google, Apple, Nvidia and Tesla account for more than one-third of the S&amp;P 500's 26% return this year, according to Goldman.</p>\n<p>Traders are awaiting a decision from the Fed on&nbsp;how quickly the central bank will tighten monetary policy&nbsp;amid a backdrop of fresh inflation numbers that reflected the fastest annual increase in nearly four decades. The Labor Department's Consumer Price Index (CPI) soared 6.8% in November compared to last year, according to figures published last week.</p>\n<p>The Federal Open Market Committee (FOMC) is scheduled to hold its two-day policy-setting meeting starting on Tuesday, followed by the release of the monetary policy statement and remarks from Federal Reserve Chair Jerome Powell Wednesday. An updated Summary of Economic Projections outlining individual members' outlooks for economic conditions and interest rates is set to accompany the statement.</p>\n<p>The Fed has been under pressure to control rising inflation levels, as investors watch for clues of a faster taper that could set the stage for earlier rate hikes.</p>\n<p>“Because inflation expectations do appear to be adaptive, our view is that the longer inflation stays elevated, the greater the risk that consumers adjust their behaviors in a way that contributes to persistently elevated inflation” wrote PIMCO economist Tiffany Wilding in a&nbsp;recent note to clients.</p>\n<p>“We believe the Fed will want to manage this risk by shortening the time over which it winds down its purchases of U.S. Treasuries and agency mortgage-backed securities (MBS), aiming to end the program in March 2022, while also signaling a June rate hike is likely,” said Wilding.</p>\n<p>PIMCO managing director and portfolio manager Sonali Pier also separately&nbsp;told Yahoo Finance Live&nbsp;that the firm expects to see two hikes in 2022, three hikes in 2023, and potentially four in 2024, with the Fed trying to bring the policy rate to neutral.</p>\n<p>“Amid proliferating signs of solid growth and a robust job market, various measures depict a deeply troubled economy,” wrote&nbsp;Oxford Economics senior economist Bob Schwartzin a new report. \"Households are downbeat, according to sentiment surveys, and the so-called 'misery index' that adds together inflation and unemployment hovers around recession levels.\"</p>\n<p>Markets&nbsp;await a trove of fresh economic data this week. November retail sales, out on Wednesday, are expected to rise by 0.8%, according to Bloomberg consensus estimates. And November housing starts are forecasted to see a month-over-month increase of 3.3%.</p>\n<p>Meanwhile, Morgan Stanley projects the U.S. unemployment rate will drop to 3% in 2022.</p>\n<p>\"It's stunning to see how much the rate has fallen in the last five months,” Morgan chief U.S. economist&nbsp;Michael Feroli told Yahoo Finance Live. “We expect that pace of decline to slow, but it doesn't take much to get below 4%, even with a tick up in the labor participation rate which has been depressed over the last year and a half.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S.Stocks open lower after PPI reading as investors await Fed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S.Stocks open lower after PPI reading as investors await Fed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-14 22:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S.Stocks open lower after PPI reading as investors await Fed,Nasdaq Composite down 1.2% at 15,229.96,S&amp;P 500 down 0.7% at 4,635.65,Dow industrials down 98 points, or 0.3%.</p>\n<p>Tesla&nbsp;shares were among the biggest early droppers on the S&amp;P 500, falling 2.1% premarket after CEO Elon Musk announced that that he has sold another $906.5 million in shares.</p>\n<p>Fellow automaker&nbsp;Ford&nbsp;also fell, down 1.7% following news that by 2030Toyotawould beinvesting $35 billion into battery-powered electronic vehicles, a space where Ford has sought to establish itself as a leader.</p>\n<p>Pfizer&nbsp;shares rose nearly 1% after final results of tests on its Covid drug showed it reduced hospitalizations and deaths by 89% in high-risk patients.</p>\n<p>Research from Goldman Sachs showed&nbsp;the S&amp;P 500 is powered by five stocks&nbsp;that have accounted for 51% of its return since the end of April. Microsoft, Google, Apple, Nvidia and Tesla account for more than one-third of the S&amp;P 500's 26% return this year, according to Goldman.</p>\n<p>Traders are awaiting a decision from the Fed on&nbsp;how quickly the central bank will tighten monetary policy&nbsp;amid a backdrop of fresh inflation numbers that reflected the fastest annual increase in nearly four decades. The Labor Department's Consumer Price Index (CPI) soared 6.8% in November compared to last year, according to figures published last week.</p>\n<p>The Federal Open Market Committee (FOMC) is scheduled to hold its two-day policy-setting meeting starting on Tuesday, followed by the release of the monetary policy statement and remarks from Federal Reserve Chair Jerome Powell Wednesday. An updated Summary of Economic Projections outlining individual members' outlooks for economic conditions and interest rates is set to accompany the statement.</p>\n<p>The Fed has been under pressure to control rising inflation levels, as investors watch for clues of a faster taper that could set the stage for earlier rate hikes.</p>\n<p>“Because inflation expectations do appear to be adaptive, our view is that the longer inflation stays elevated, the greater the risk that consumers adjust their behaviors in a way that contributes to persistently elevated inflation” wrote PIMCO economist Tiffany Wilding in a&nbsp;recent note to clients.</p>\n<p>“We believe the Fed will want to manage this risk by shortening the time over which it winds down its purchases of U.S. Treasuries and agency mortgage-backed securities (MBS), aiming to end the program in March 2022, while also signaling a June rate hike is likely,” said Wilding.</p>\n<p>PIMCO managing director and portfolio manager Sonali Pier also separately&nbsp;told Yahoo Finance Live&nbsp;that the firm expects to see two hikes in 2022, three hikes in 2023, and potentially four in 2024, with the Fed trying to bring the policy rate to neutral.</p>\n<p>“Amid proliferating signs of solid growth and a robust job market, various measures depict a deeply troubled economy,” wrote&nbsp;Oxford Economics senior economist Bob Schwartzin a new report. \"Households are downbeat, according to sentiment surveys, and the so-called 'misery index' that adds together inflation and unemployment hovers around recession levels.\"</p>\n<p>Markets&nbsp;await a trove of fresh economic data this week. November retail sales, out on Wednesday, are expected to rise by 0.8%, according to Bloomberg consensus estimates. And November housing starts are forecasted to see a month-over-month increase of 3.3%.</p>\n<p>Meanwhile, Morgan Stanley projects the U.S. unemployment rate will drop to 3% in 2022.</p>\n<p>\"It's stunning to see how much the rate has fallen in the last five months,” Morgan chief U.S. economist&nbsp;Michael Feroli told Yahoo Finance Live. “We expect that pace of decline to slow, but it doesn't take much to get below 4%, even with a tick up in the labor participation rate which has been depressed over the last year and a half.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179453620","content_text":"U.S.Stocks open lower after PPI reading as investors await Fed,Nasdaq Composite down 1.2% at 15,229.96,S&P 500 down 0.7% at 4,635.65,Dow industrials down 98 points, or 0.3%.\nTesla shares were among the biggest early droppers on the S&P 500, falling 2.1% premarket after CEO Elon Musk announced that that he has sold another $906.5 million in shares.\nFellow automaker Ford also fell, down 1.7% following news that by 2030Toyotawould beinvesting $35 billion into battery-powered electronic vehicles, a space where Ford has sought to establish itself as a leader.\nPfizer shares rose nearly 1% after final results of tests on its Covid drug showed it reduced hospitalizations and deaths by 89% in high-risk patients.\nResearch from Goldman Sachs showed the S&P 500 is powered by five stocks that have accounted for 51% of its return since the end of April. Microsoft, Google, Apple, Nvidia and Tesla account for more than one-third of the S&P 500's 26% return this year, according to Goldman.\nTraders are awaiting a decision from the Fed on how quickly the central bank will tighten monetary policy amid a backdrop of fresh inflation numbers that reflected the fastest annual increase in nearly four decades. The Labor Department's Consumer Price Index (CPI) soared 6.8% in November compared to last year, according to figures published last week.\nThe Federal Open Market Committee (FOMC) is scheduled to hold its two-day policy-setting meeting starting on Tuesday, followed by the release of the monetary policy statement and remarks from Federal Reserve Chair Jerome Powell Wednesday. An updated Summary of Economic Projections outlining individual members' outlooks for economic conditions and interest rates is set to accompany the statement.\nThe Fed has been under pressure to control rising inflation levels, as investors watch for clues of a faster taper that could set the stage for earlier rate hikes.\n“Because inflation expectations do appear to be adaptive, our view is that the longer inflation stays elevated, the greater the risk that consumers adjust their behaviors in a way that contributes to persistently elevated inflation” wrote PIMCO economist Tiffany Wilding in a recent note to clients.\n“We believe the Fed will want to manage this risk by shortening the time over which it winds down its purchases of U.S. Treasuries and agency mortgage-backed securities (MBS), aiming to end the program in March 2022, while also signaling a June rate hike is likely,” said Wilding.\nPIMCO managing director and portfolio manager Sonali Pier also separately told Yahoo Finance Live that the firm expects to see two hikes in 2022, three hikes in 2023, and potentially four in 2024, with the Fed trying to bring the policy rate to neutral.\n“Amid proliferating signs of solid growth and a robust job market, various measures depict a deeply troubled economy,” wrote Oxford Economics senior economist Bob Schwartzin a new report. \"Households are downbeat, according to sentiment surveys, and the so-called 'misery index' that adds together inflation and unemployment hovers around recession levels.\"\nMarkets await a trove of fresh economic data this week. November retail sales, out on Wednesday, are expected to rise by 0.8%, according to Bloomberg consensus estimates. And November housing starts are forecasted to see a month-over-month increase of 3.3%.\nMeanwhile, Morgan Stanley projects the U.S. unemployment rate will drop to 3% in 2022.\n\"It's stunning to see how much the rate has fallen in the last five months,” Morgan chief U.S. economist Michael Feroli told Yahoo Finance Live. “We expect that pace of decline to slow, but it doesn't take much to get below 4%, even with a tick up in the labor participation rate which has been depressed over the last year and a half.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":566,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607193301,"gmtCreate":1639494891266,"gmtModify":1639494895480,"author":{"id":"4102250035568310","authorId":"4102250035568310","name":"Solluce","avatar":"https://static.tigerbbs.com/646eb0ac8d22985e48ba886e5c0e7fc4","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like pls. Ty!","listText":"Like pls. Ty!","text":"Like pls. Ty!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/607193301","repostId":"2191930972","repostType":4,"repost":{"id":"2191930972","pubTimestamp":1639489168,"share":"https://www.laohu8.com/m/news/2191930972?lang=&edition=full","pubTime":"2021-12-14 21:39","market":"us","language":"en","title":"2 Warren Buffett Dividend Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2191930972","media":"Motley Fool","summary":"AbbVie and Royalty Pharma should be on every dividend investor's radar right now.","content":"<p><b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.</p>\n<p>As a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.</p>\n<p>Which Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks <b>AbbVie</b> (NYSE:ABBV) and <b>Royalty Pharma</b> (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.</p>\n<h2>AbbVie: A high-yield growth stock</h2>\n<p>Berkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest yields among major drug manufacturers.</p>\n<p>Second, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.</p>\n<p>Lastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.</p>\n<p>The net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.</p>\n<h2>Royalty Pharma: A dependable revenue stream</h2>\n<p>Royalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.</p>\n<p><img src=\"https://static.tigerbbs.com/a320f51af9bb7ac0d6359af7ed64161a\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>RPRX data by YCharts</p>\n<p>Why is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.</p>\n<p>Now, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Warren Buffett Dividend Stocks to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Warren Buffett Dividend Stocks to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 21:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4007":"制药","BK4534":"瑞士信贷持仓","RPRX":"Royalty Pharma plc","BRK.A":"伯克希尔","ABBV":"艾伯维公司","BRK.B":"伯克希尔B","BK4559":"巴菲特持仓","BK4176":"多领域控股","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191930972","content_text":"Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.\nAs a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.\nWhich Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks AbbVie (NYSE:ABBV) and Royalty Pharma (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.\nAbbVie: A high-yield growth stock\nBerkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's one of the highest yields among major drug manufacturers.\nSecond, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.\nLastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.\nThe net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.\nRoyalty Pharma: A dependable revenue stream\nRoyalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.\n\nRPRX data by YCharts\nWhy is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.\nNow, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.","news_type":1},"isVote":1,"tweetType":1,"viewCount":424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":607193301,"gmtCreate":1639494891266,"gmtModify":1639494895480,"author":{"id":"4102250035568310","authorId":"4102250035568310","name":"Solluce","avatar":"https://static.tigerbbs.com/646eb0ac8d22985e48ba886e5c0e7fc4","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like pls. Ty!","listText":"Like pls. Ty!","text":"Like pls. Ty!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/607193301","repostId":"2191930972","repostType":4,"repost":{"id":"2191930972","pubTimestamp":1639489168,"share":"https://www.laohu8.com/m/news/2191930972?lang=&edition=full","pubTime":"2021-12-14 21:39","market":"us","language":"en","title":"2 Warren Buffett Dividend Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2191930972","media":"Motley Fool","summary":"AbbVie and Royalty Pharma should be on every dividend investor's radar right now.","content":"<p><b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.</p>\n<p>As a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.</p>\n<p>Which Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks <b>AbbVie</b> (NYSE:ABBV) and <b>Royalty Pharma</b> (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.</p>\n<h2>AbbVie: A high-yield growth stock</h2>\n<p>Berkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest yields among major drug manufacturers.</p>\n<p>Second, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.</p>\n<p>Lastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.</p>\n<p>The net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.</p>\n<h2>Royalty Pharma: A dependable revenue stream</h2>\n<p>Royalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.</p>\n<p><img src=\"https://static.tigerbbs.com/a320f51af9bb7ac0d6359af7ed64161a\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>RPRX data by YCharts</p>\n<p>Why is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.</p>\n<p>Now, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Warren Buffett Dividend Stocks to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Warren Buffett Dividend Stocks to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 21:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4007":"制药","BK4534":"瑞士信贷持仓","RPRX":"Royalty Pharma plc","BRK.A":"伯克希尔","ABBV":"艾伯维公司","BRK.B":"伯克希尔B","BK4559":"巴菲特持仓","BK4176":"多领域控股","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191930972","content_text":"Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.\nAs a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.\nWhich Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks AbbVie (NYSE:ABBV) and Royalty Pharma (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.\nAbbVie: A high-yield growth stock\nBerkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's one of the highest yields among major drug manufacturers.\nSecond, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.\nLastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.\nThe net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.\nRoyalty Pharma: A dependable revenue stream\nRoyalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.\n\nRPRX data by YCharts\nWhy is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.\nNow, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.","news_type":1},"isVote":1,"tweetType":1,"viewCount":424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690645245,"gmtCreate":1639666403489,"gmtModify":1639666403558,"author":{"id":"4102250035568310","authorId":"4102250035568310","name":"Solluce","avatar":"https://static.tigerbbs.com/646eb0ac8d22985e48ba886e5c0e7fc4","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Kay","listText":"Kay","text":"Kay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690645245","repostId":"1171328517","repostType":4,"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607191106,"gmtCreate":1639494999427,"gmtModify":1639494999491,"author":{"id":"4102250035568310","authorId":"4102250035568310","name":"Solluce","avatar":"https://static.tigerbbs.com/646eb0ac8d22985e48ba886e5c0e7fc4","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like pls!","listText":"Like pls!","text":"Like pls!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607191106","repostId":"1179453620","repostType":4,"isVote":1,"tweetType":1,"viewCount":566,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607550748,"gmtCreate":1639568109027,"gmtModify":1639568109255,"author":{"id":"4102250035568310","authorId":"4102250035568310","name":"Solluce","avatar":"https://static.tigerbbs.com/646eb0ac8d22985e48ba886e5c0e7fc4","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like pls, ty!","listText":"Like pls, ty!","text":"Like pls, ty!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607550748","repostId":"1160618167","repostType":4,"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}